J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 84 (2003), 2105-2109; DOI 10.1099/vir.0.18995-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laukkanen, P.
Right arrow Articles by Lehtinen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laukkanen, P.
Right arrow Articles by Lehtinen, M.
Agricola
Right arrow Articles by Laukkanen, P.
Right arrow Articles by Lehtinen, M.
© 2003 Society for General Microbiology

Short Communication

Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland

Päivi Laukkanen1,2, Pentti Koskela1, Eero Pukkala2, Joakim Dillner3, Esa Läärä4, Paul Knekt1 and Matti Lehtinen1

1 National Public Health Institute, Helsinki and Oulu, Mannerheimintie 166, 00300 Helsinki, Finland
2 Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
3 University of Lund, Malmö, Sweden
4 University of Oulu, Oulu, Finland

Correspondence
Matti Lehtinen
llmale{at}uta.fi

Human papillomavirus (HPV) type 16 is the major cause of cervical carcinoma, the incidence of which is decreasing in western countries. In Finland the incidence is, however, increasing in women aged <40 years, but possible underlying changes in HPV-16 epidemiology are unknown. To assess incidence trends of HPV infections, paired sera from a random sample of 8000 women with two pregnancies/sera within 5 years, taken from the serum bank of the Finnish Maternity Cohort (1983–98), were analysed for HPV-6, -11 and -16 antibodies. For 23–31-year-old women, HPV-16 incidence increased over the period 1983–97. HPV-16 seroprevalence increased from 17 % in 1983–85 to 24 % in 1995–97, but HPV-6 and HPV-11 prevalence was stable at 9–12 % throughout the study period. Epidemic spread of the oncogenic HPV-16, but not the non-oncogenic HPV-types, throughout the 1980s and 1990s preceded an increase in the incidence of cervical carcinoma in fertile-aged Finnish women.




This article has been cited by other articles:


Home page
 Sex. Transm. Infect.Home page
E Lyytikainen, M Kaasila, P Koskela, M Lehtinen, T Patama, E Pukkala, K Tasanen, H-M Surcel, and J Paavonen
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003
Sex Transm Inf, February 1, 2008; 84(1): 19 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Bray, B. Carstensen, H. Moller, M. Zappa, M. P. Zakelj, G. Lawrence, M. Hakama, and E. Weiderpass
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2191 - 2199.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
D. Dias, J. Van Doren, S. Schlottmann, S. Kelly, D. Puchalski, W. Ruiz, P. Boerckel, J. Kessler, J. M. Antonello, T. Green, et al.
Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18
Clin. Vaccine Immunol., August 1, 2005; 12(8): 959 - 969.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2003 by the Society for General Microbiology.